Lauren Fishbein is an Endocrinology/Metabolic physician affiliated with University of Colorado Cancer Center. OpenAlex indexes 143 publications with 5,104 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
100%l-Thyroxine50%Levothyroxine Sodium100%Part D<11 patientsMineralocorticoids30.4%Fludrocortisone Acetate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- Genetic Risk for Aggressive Thyroid Cancer in an Understudied Male Predominant Veteran Population
Va Eastern Colorado Health Care System
FY2025I01BX006252 - Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
University of Colorado Denver
FY2024$337,990R01CA246586 - Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
University of Colorado Denver
FY2023$348,660R01CA246586
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Population Prevalence of the Major Thyroid Cancer–Associated Syndromes
The Journal of Clinical Endocrinology & Metabolism
2025 - Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
JNCI Journal of the National Cancer Institute
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Bryan Haugen, MD
University of Colorado Cancer Center
Wells Messersmith, MD
University of Colorado Cancer Center
Thomas Flaig, MD
University of Colorado Cancer Center
Christopher Lieu, MD
University of Colorado Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”